Divis Laboratories Ltd, a leading manufacturer and exporter of APIs, intermediates, and nutraceutical ingredients, reported strong financial results for Q2FY26. Financial Highlights:
Divis Laboratories Q2 FY26 Earnings Results
Categories
nutraceutical
EID Parry Q1 FY26 Earnings Results
EID Parry (India) Limited is engaged in the production of sugar, nutraceuticals, and ethanol, and has a significant presence in the farm
EID Parry (India) Ltd Q4FY25; 83% rise in Profits
EID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including
Divis Laboratories Ltd Q4FY25; 23% rise in Profits
Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for
Divis Laboratories Ltd Q3FY25; 65% rise in Profits
Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for
Divis Laboratories Ltd Q2FY25; 47% rise in Profits
Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for
Zota Health Care Ltd Q1FY24; 32% rise in Revenue
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across
Vaishali Pharma Ltd Q1FY24; 5% rise in Profits
Incorporated in 1989, Vaishali Pharma Ltd. is engaged in the manufacturing, trading & marketing of Active Pharmaceutical Ingredients(APIs), pharmaceuticals formulations, surgical products,